EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Mepolizumab provides sustained clinical benefits in patients with severe asthma regardless of age of asthma onset: Real-world data from the REALITI-A study at 2 years

Sunday 15 Jun, 16:45 PM - 16:57 PM Glasgow, United Kingdom